Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 400
- 试验地点
- 2
- 主要终点
- The cumulative incidence of symptomatic CTEPH
研究概览
简要总结
Chronic thromboembolic pulmonary hypertension (CTPH) is associated with considerable morbidity and mortality. Its incidence after pulmonary embolism and associated risk factors are not well documented in Chinese population. We conducted a prospective, long-term, follow-up study to assess the incidence of symptomatic CTPH in consecutive patients with an acute episode of pulmonary embolism but without prior venous thromboembolism. Patients with unexplained persistent dyspnea during follow-up underwent transthoracic echocardiography and, if supportive findings were present, ventilation-perfusion lung scanning and pulmonary angiography. CTPH was considered to be present if systolic and mean pulmonary-artery pressures exceeded 40 mm Hg and 25 mm Hg, respectively; pulmonary-capillary wedge pressure was normal; and there was angiographic evidence of disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with an episode of acute symptomatic pulmonary embolism without prior pulmonary embolism or venous thrombosis
排除标准
- •Have other diseases (e.g., systemic sclerosis or severe emphysema) that could have caused nonthromboembolic pulmonary hypertension,
- •Have preexisting exertional dyspnea,
- •Geographically inaccessible for follow-up,
- •Decline to participate in the study.
结局指标
主要结局
The cumulative incidence of symptomatic CTEPH
时间窗: 2 years
次要结局
- Risk factors for Recurrent VTE and CTEPH(2 years)
研究者
Shengqing Li
MD, PhD, Associate Chief Physician, Associate Professor
Air Force Military Medical University, China
